Remove Groups Remove healthcare technology Remove Leadership Remove Mental health
article thumbnail

Is Mental Health ready for Generative AI?

Lloyd Price

It is important to ensure that these models are not used to generate content that could be harmful to individuals or groups. With continued development, generative AI could be used to: Provide therapy and support: Generative AI models could be used to provide therapy and support to individuals with mental health conditions.

article thumbnail

Kyruus Expands Leadership Team with Addition of New Chief Product Officer Peter Boumenot

Digital Health Global

In this role, Boumenot will drive the company’s product strategy and roadmap, helping catalyze the next phase of Kyruus’ evolution as the healthcare industry’s foundational platform powering the digital infrastructure that enables people to connect to the right care. Before that, he was the Chief Product Officer for Signify Health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

It’s Private: Innovative Techniques Begin to Address Clinicians’ Mental Health

Healthcare IT Today

Those that have been impacted the greatest of any group have been our physicians, nurses, therapists, and other healthcare professionals. The human brain is not designed to withstand the stimulation and endless distractions of modern, technology-laden lifestyles. And declines aren’t solely a cognitive concern.

article thumbnail

Digital Phenotyping: emerging HealthTech sub sector is 'one to watch in 2024 and 2025'

Lloyd Price

Here are some of the potential benefits of digital phenotyping: Improved diagnosis and treatment of mental health conditions: Digital phenotyping can be used to identify early signs of mental health problems and track the effectiveness of treatment. This allows for early intervention and targeted support.

article thumbnail

Platform Trials emerging as new study types for evaluating Digital Health solutions

Lloyd Price

Platform Trials: Test multiple treatments against a shared control group. Why Platform Trials are Ideal for Digital Health Rapid Evolution: Digital health solutions change rapidly. Chronic Diseases: Platform trials can evaluate digital health tools for managing chronic conditions like diabetes or heart disease.

article thumbnail

Digital Musculoskeletal Investment Trends 2024 and Future Innovation in the Digital MSK market

Lloyd Price

Integration with Mental Health Care: There's a strong link between chronic pain and mental health. Digital MSK platforms may integrate with mental health resources to provide a more holistic approach to patient well-being. Visit www.nelsonadvisors.co.uk Visit www.nelsonadvisors.co.uk Subscribe Today!

article thumbnail

Corporate Venture Capital's growing role and importance in HealthTech

Lloyd Price

Merck Ventures: Merck Ventures has invested in a range of healthtech startups, including Clue, GlycoMimetics, and AbCellera, demonstrating its interest in areas such as women's health, oncology, and immunotherapy. In 2021, Omada Health was acquired by UnitedHealth Group for $5 billion.